medigraphic.com
ISSN 2594-1526 (Electronic)
Antes Revista del Instituto Nacional de Enfermedades Respiratorias

 Ver anteriores al 2010

2020, Number 2

<< Back Next >>

Neumol Cir Torax 2020; 79 (2)

How silent is hypoxemia in COVID-19?

Pérez-Padilla JR, Thirión-Romero II, Aguirre-Pérez T, Rodríguez-Llamazares S

Language: Spanish
References: 13
Page: 69-70
PDF size: 170.57 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med 2020;46(5):837-840. https://doi.org/10.1007/s00134-020-05979-7

  2. Ottestad W, Seim M, Maehlen JO. COVID-19 with silent hypoxemia. Tidsskr Nor Laegeforen 2020;140(7): https://doi.org/10.4045/tidsskr.20.0299

  3. Vazquez-Garcia JC, Arellano-Vega SL, Regalado-Pineda J, Perez-Padilla JR. Normal ventilatory response to hypoxia and hypercapnia at an altitude of 2240 meters. Rev Invest Clin. 1998;50(4):323-329.

  4. Coen M, Allali G, Adler D, Serratrice J. Hypoxemia in COVID-19; Comment on: “The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients”. J Med Virol 2020;10. https://doi.org/10.1002/jmv.26020

  5. Lee LY. Respiratory sensations evoked by activation of bronchopulmonary C-fibers. Respir Physiol Neurobiol 2009;167(1):26-35. https://doi.org/10.1016/j.resp.2008.05.006

  6. Xie J, Covassin N, Fan Z, et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clinic proceedings 2020;95(6):P1138-1147. https://doi.org/10.1016/j.mayocp.2020.04.006

  7. Pérez-Padilla R, García-Sancho C, Fernández R, Franco-Marina F, López-Gatell H, Bojórquez I. The impact of altitude on hospitalization and hospital mortality from pandemic 2009 influenza A (H1N1) virus pneumonia in Mexico. Salud Publica Mex 2013;55(1):92-95. https://doi.org/10.1590/s0036-36342013000100013

  8. Pérez-Padilla R, Franco-Marina F. The impact of altitude on mortality from tuberculosis and pneumonia. Int J Tuberc Lung Dis 2004;8(11):1315-1320.

  9. Hanly PJ, Roberts D, Dobson K, Light RB. Effect of indomethacin on arterial oxygenation in critically ill patients with severe bacterial pneumonia. Lancet 1987;1(8529):351-354. https://doi.org/10.1016/s0140-6736(87)91727-2

  10. Light RB. Indomethacin and acetylsalicylic acid reduce intrapulmonary shunt in experimental pneumococcal pneumonia. Am Rev Respir Dis 1986;134(3):520-525. https://doi.org/10.1164/arrd.1986.134.3.520

  11. McCormack DG, Crawley DE, Evans TW. New perspectives in the pulmonary circulation and hypoxic pulmonary vasoconstriction. Pulm Pharmacol 1993;6(2):97-108. https://doi.org/10.1006/pulp.1993.1013

  12. Lang M, Som A, Mendoza DP, et al. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. Lancet Infect Dis 2020. https://doi.org/10.1016/s1473-3099(20)30367-4

  13. Masera O, Riojas-Rodríguez H, Pérez-Padilla R, et al. Vulnerabilidad a COVID-19 en poblaciones rurales y periurbanas por el uso doméstico de leña. 2020 [Available from: https://http://www.insp.mx/avisos/5386-vulnerabilidad-covid-19-poblaciones-rurales.html




2020     |     www.medigraphic.com